Illumina Body Map 2 (GSE30611)
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr6_+_159969070 Show fit | 0.78 |
ENST00000356956.6
|
insulin like growth factor 2 receptor |
|
chr1_+_154405193 Show fit | 0.57 |
ENST00000622330.4
ENST00000344086.8 |
interleukin 6 receptor |
|
chr3_-_115071333 Show fit | 0.56 |
ENST00000462705.5
|
zinc finger and BTB domain containing 20 |
|
chr11_-_57515686 Show fit | 0.56 |
ENST00000533263.1
ENST00000278426.8 |
solute carrier family 43 member 1 |
|
chr2_+_5692357 Show fit | 0.52 |
ENST00000322002.5
|
SRY-box transcription factor 11 |
|
chr12_+_54008961 Show fit | 0.51 |
ENST00000040584.6
|
homeobox C8 |
|
chr16_+_68085552 Show fit | 0.50 |
ENST00000329524.8
|
nuclear factor of activated T cells 3 |
|
chr5_-_128538230 Show fit | 0.49 |
ENST00000262464.9
|
fibrillin 2 |
|
chr15_+_41231219 Show fit | 0.47 |
ENST00000334660.10
ENST00000560397.5 |
calcineurin like EF-hand protein 1 |
|
chr22_+_40177917 Show fit | 0.39 |
ENST00000454349.7
ENST00000335727.13 |
trinucleotide repeat containing adaptor 6B |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.6 | GO:0002384 | hepatic immune response(GO:0002384) |
0.1 | 0.5 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.1 | 0.5 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.1 | 0.5 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.0 | 0.5 | GO:0040033 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 | 0.5 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.1 | 0.4 | GO:0042851 | L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
0.1 | 0.3 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.1 | 0.3 | GO:0036510 | trimming of terminal mannose on C branch(GO:0036510) |
0.1 | 0.3 | GO:0009107 | lipoate biosynthetic process(GO:0009107) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.6 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.4 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.4 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 0.3 | GO:0031905 | early endosome lumen(GO:0031905) |
0.0 | 0.3 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.0 | 0.3 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 0.3 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.1 | 0.2 | GO:1990843 | subsarcolemmal mitochondrion(GO:1990843) interfibrillar mitochondrion(GO:1990844) |
0.0 | 0.2 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.8 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.1 | 0.6 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
0.0 | 0.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 0.5 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.1 | 0.4 | GO:0047635 | L-alanine:2-oxoglutarate aminotransferase activity(GO:0004021) alanine-oxo-acid transaminase activity(GO:0047635) |
0.0 | 0.3 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.0 | 0.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.3 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 0.3 | GO:0034046 | poly(G) binding(GO:0034046) |
0.0 | 0.3 | GO:0051434 | BH3 domain binding(GO:0051434) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.9 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.7 | ST STAT3 PATHWAY | STAT3 Pathway |
0.0 | 0.7 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.7 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.0 | 0.5 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 0.4 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.3 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.0 | 0.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |